Venture Life Group PLC Trading Update and Notice of Results (3602F)
09 Marzo 2020 - 8:00AM
UK Regulatory
TIDMVLG
RNS Number : 3602F
Venture Life Group PLC
09 March 2020
Venture Life Group plc
("Venture Life" or the "Company")
Trading Update and Notice of Results
Venture Life Group plc (AIM: VLG), a leader in developing,
manufacturing and commercialising products for the international
self-care market, provides an update on current trading ahead of
announcing it full year results. The Company is pleased to announce
that it has made a strong start to 2020. The integration of
PharmaSource BV, acquired in December last year is going according
to plan and the Company's order book remains strong. In particular,
the expected growth in orders from China, referred to in the
Company's trading statement of 19 December 2019, has materialised
and, whilst still early in the year, orders from China are
exceeding expectations.
Safety of our employees is our prime concern, and the Company
has taken reasonable and appropriate precautions to protect against
any impact from COVID-19 at its Biokosmes facility. The Company
holds ample stocks for production and packaging and now has
additional reserve stock. The Company has not experienced
absenteeism over what would normally be expected at this time of
year and is pleased to note that there has been no impact to
production. Also the Company can confirm that despite the
quarantine restrictions announced this weekend in the Region of
Lombardy, shipments to customers and from suppliers outside of the
Region of Lombardy will not be affected, as they are not prohibited
under the quarantine regulations.
Notice of Results
The Company expects to announce its results for the year ended
31 December 2019 on 26 March 2020.
Jerry Randall, Chief Executive Officer of Venture Life,
commented: "We are pleased to report that our strong order book
going into Q1 has been converting to sales during the current
trading period. We remain well stocked and have appropriate
contingency plans in place to ensure all parts of the supply chain
are maintained, and we continue to see good levels of demand across
all areas of our business. We look forward to providing a further
update at the time of our full year results."
For further information, please contact:
Venture Life Group plc +44(0) 1344 578004
Jerry Randall, Chief Executive Officer
Cenkos Securities plc (Nomad and Broker) +44(0)20 7397 8900
Mark Connelly / Stephen Keys / Cameron MacRitchie
(Corporate Finance)
Russell Kerr / Michael Johnson (Sales)
Alma PR +44(0)20 3405 0208
Hilary Buchanan / Helena Bogle / Kieran Breheny
About Venture Life ( www.venture-life.com )
Venture Life is an international consumer self-care company
focused on acquiring, developing, manufacturing and commercialising
products for the global self-care market. With operations in the
UK, Italy and the Netherlands, the Group's product portfolio
includes some key products such as the UltraDEX and Dentyl oral
care product ranges, , medical devices for dermatology, oral care,
women's intimate healthcare and proctology, and dermo-cosmetics for
addressing the signs of ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies and grocery multiples. In the UK and the Netherlands
these are supplied direct by the company, elsewhere they are
supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies in the OTC consumer products sector,
primarily in respect of medical devices.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TSTFFFSFVFITIII
(END) Dow Jones Newswires
March 09, 2020 03:00 ET (07:00 GMT)
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Apr 2023 a Apr 2024